Clinical Trial: Refusal of Sentinel Lymph Node Biopsy in Patients With Luminal A Subtype Early Breast Cancer

U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07579286) titled 'Refusal of Sentinel Lymph Node Biopsy in Patients With Luminal A Subtype Early Breast Cancer' on May 06.

Brief Summary: Sentinel lymph node biopsy (SLNB) is the standard of axillary lymph node surgical staging in patients with early breast cancer.

The main goal of the study is to abandon axillary surgery in patients over 59 years old with early, luminal A, clinical lymph node negative breast cancer.

Study Start Date: July 27, 2023

Study Type: INTERVENTIONAL

Condition: Early Breast Cancer

Intervention: PROCEDURE: breast resection

breast resection without sentinel lymph node biopsy, radiotherapy to the breast area and sentinel ...